Bellur S Prabhakar (Bellur Prabhakar)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 18

Top Venues

Cancer gene therapy

BMJ open

Journal of immunology (Baltimore, Md. : 1950)

Oncogene

University of Illinois at Chicago

Johns Hopkins University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Illinois at Chicago

United States

Professor and Head; Associate Dean for Research and Training Programs :: Microbiology and Immunology

University of Illinois at Chicago

United States

Professor and Head :: Microbiology and Imunology

University of Texas Medical Branch at Galveston

United States

Professor :: Microbiology and Immunology

University of Texas Medical Center

United States

Associate Professor :: Microbiology and Immunology

National Institutes of Health

United States

Senior Investigator with Tenure :: Laboratory od Oral Medicine

National Institutes of Health

United States

Senior Staff Fellow :: Laboratory of Oral Medicine

National Institutes of Health

United States

Saff Fellow :: Laboratory of Oral Medicine

University of Pennsylvania

United States

Post-Doctoral Fellow :: Microbiology and Immunology

Johns Hopkins University Bloomberg School of Public Health

United States

Research Assistant :: Epidemiology/Infectious Diseases

Education History

Johns Hopkins University

United States

PHD :: Epidemiology/Infectious Diseases

University of Mysore

India

MSC :: Microbiology

University of Mysore

India

BSC

Publications

Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy 31 (4) (2024)
Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy 31 (4) (2024)
Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy (2024)
Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy 31 (4) (2024)
Vaidya Ruchi, Chaudhury Nayanjeet, Pramila Kalra, K Sreekumaran Nair, Bellur S Prabhakar
Effects of almond consumption compared with the consumption of traditional isocaloric cereal/pulse-based snacks on glycaemic control and gut health in adults with pre-diabetes in rural India: protocol for a 16-week, parallel-arm, cluster randomised controlled trial. BMJ open 14 (7) (2024)
Vaidya Ruchi, Chaudhury Nayanjeet, Pramila Kalra, K Sreekumaran Nair, Bellur S Prabhakar
Effects of almond consumption compared with the consumption of traditional isocaloric cereal/pulse-based snacks on glycaemic control and gut health in adults with pre-diabetes in rural India: protocol for a 16-week, parallel-arm, cluster randomised controlled trial. BMJ open 14 (7) (2024)
Rashmi Kadam, Muskan Gupta, Orly Lazarov, Bellur S Prabhakar
Brain-Immune interactions: Implication for Cognitive impairments in Alzheimer's Disease and autoimmune disorders. Journal of leukocyte biology (2024)
Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy 31 (4) (2024)
Vaidya Ruchi, Chaudhury Nayanjeet, Pramila Kalra, K Sreekumaran Nair, Bellur S Prabhakar
Effects of almond consumption compared with the consumption of traditional isocaloric cereal/pulse-based snacks on glycaemic control and gut health in adults with pre-diabetes in rural India: protocol for a 16-week, parallel-arm, cluster randomised controlled trial. BMJ open 14 (7) (2024)
Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy (2024)
Vaidya Ruchi, Chaudhury Nayanjeet, Pramila Kalra, K Sreekumaran Nair, Bellur S Prabhakar
Effects of almond consumption compared with the consumption of traditional isocaloric cereal/pulse-based snacks on glycaemic control and gut health in adults with pre-diabetes in rural India: protocol for a 16-week, parallel-arm, cluster randomised controlled trial. BMJ open 14 (7) (2024)
Soon Cheon Shin, Renee E Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy A Mangold, Bellur S Prabhakar, Hans Schreiber, Weidong Xu
The safety and efficacy of systemic delivery of a new liver-de-targeted TGFβ signaling inhibiting adenovirus in an immunocompetent triple negative mouse mammary tumor model. Cancer gene therapy 31 (4) (2024)
Weidong Xu, Soon Cheon Shin, Renee Vickman, Beniamin Filimon, Yuefeng Yang, Zebin Hu, Kathy Mangold, Bellur S Prabhakar, Hans Schreiber
The Safety and Efficacy of Systemic Delivery of a New Liver-de-targeted TGFβ Signaling Inhibiting Adenovirus in an Immunocompetent Triple Negative Mouse Mammary Tumor Model. Research square (2023)
Guilin Qiao, Lyonell B Kone, Evan H Phillips, Steve Seung-Young Lee, Grace E Brown, Salman R Khetani, Archana Thakur, Lawrence G Lum, Bellur S Prabhakar, Ajay V Maker
LIGHT enhanced bispecific antibody armed T-cells to treat immunotherapy resistant colon cancer. Oncogene 41 (14) (2022)
Prabhakaran Kumar, Sivasangari Balakrishnan, Swarali Surendra Lele, Suman Setty, Shaurya Dhingra, Alan L Epstein, Bellur S Prabhakar
Restoration of Follicular T Regulatory/Helper Cell Balance by OX40L-JAG1 Cotreatment Suppresses Lupus Nephritis in NZBWF1/j Mice. Journal of immunology (Baltimore, Md. : 1950) 208 (11) (2022)
Prabhakaran Kumar, Swarali Surendra Lele, Vandhana K Ragothaman, Divya Raghunathan, Alan L Epstein, Shigeru Chiba, Bellur S Prabhakar
OX40L-JAG1-Induced Expansion of Lineage-Stable Regulatory T Cells Involves Noncanonical NF-κB Signaling. Journal of immunology (Baltimore, Md. : 1950) 203 (12) (2019)
Shikha Saini, Kiara Tulla, Ajay V Maker, Kenneth D Burman, Bellur S Prabhakar
Therapeutic advances in anaplastic thyroid cancer: a current perspective. Molecular cancer 17 (1) (2018)
Thessicar E Antoine, Satvik R Hadigal, Abraam M Yakoub, Yogendra Kumar Mishra, Palash Bhattacharya, Christine Haddad, Tibor Valyi-Nagy, Rainer Adelung, Bellur S Prabhakar, Deepak Shukla
Intravaginal Zinc Oxide Tetrapod Nanoparticles as Novel Immunoprotective Agents against Genital Herpes. Journal of immunology (Baltimore, Md. : 1950) 196 (11) (2016)

Bellur S Prabhakar.css-eqlu8i{font-size:small;padding-left:4px;} (Bellur Prabhakar)

Publication Activity (10 Years)

Top Topics

Top Venues

Bellur S Prabhakar (Bellur Prabhakar)